Xiangzhi Meng

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M ^pro and cathepsin L

M. Sacco, Chunlong Ma, Panagiotis Lagarias et al. · Science Advances · 2020 · 399 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +14

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

Shuofeng Yuan, Xin Yin, Xiangzhi Meng et al. · Nature · 2021 · 211 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay

Chunlong Ma, M. Sacco, Zilei Xia et al. · ACS Central Science · 2021 · 198 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +14

The <i>in vitro</i> antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor

Yanmei Hu, Xiangzhi Meng, Fushun Zhang et al. · Emerging Microbes & Infections · 2021 · 188 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors

Naoya Kitamura, M. Sacco, Chunlong Ma et al. · Journal of Medicinal Chemistry · 2021 · 165 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14